More interestingly, our histological analyses demonstrated that the transplantation of SDF1α-eMSCs reduced the number of ghost cells and necrotic myofibers but enhanced the number of regenerated myofibers even at an early stage (one week post-ischemia; Fig. 6i–l). This evidence concerns the gene CXCL12 and ischemia.